Planta Med 2008; 74 - PC112
DOI: 10.1055/s-0028-1084630

Study on the isolation of bioactive components and the identification of biomarker genes from Ostericum koreanum Maximowicz

SY Choung 2, JK Hong 2, KW Lee 3, CK Lee 3, YS Kwon 4, S Shin 1
  • 1College of Pharmacy, Duksung Women's University, 132–714, Korea
  • 2College of Pharmacy, Kyung Hee University
  • 3Korea University
  • 4College of Pharmacy, Kangwon National University

Ostericum koreanum (Umbelliferae) is a perennial herb used in traditional Korean medicines for treatment of the common cold and for relief of rheumatic pains or headaches the herb imparts a pungent and warm sensation. From the dried roots of this plants, twelve pure compounds were isolated. We investigated pharmacological effects of 70% ethanol extract and other individual components purified from Ostericum. We observed that NO production by LPS stimulation in Raw cell line was strongly reduced at 70% ethanol extract treatment. The same effects were observed in mice experiments. However, none of the individual components showed the effect. In addition, 70% ethanol extract inhibited the production of cytokines including TNF-α, IL-1beta, IL-6 by LPS stimulation at RAW cell line. The 70% ethanol extract inhibited the PGE2 production by LPS stimulation, and other individual components showed the same trend. We isolated biomarker genes including Nuclear receptor subfamily 4, group A, member 2 (Nr4a2), Chemikine (C-C motif) receptor-like 2 (Ccrl2), and Interleukin 6 (Il6). Also the simutaneous analytical method of marker compounds isolated from Ostericum koreanum has been developed by using HPLC-UV technique. These marker-compounds have been successfully separated from intereference extracted from matrix in HPLC chromatogram. In ESI-MS/MS spectra, these compounds produced characteristic ions through collisional-induced dissociation.

Acknowledgements: This study was supported by a grant from Korea Food & Drug Administration (2006).

References: 1. Shin, S. (2005) Arch Pharm Res 27: 295–299.